Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine

Infection and Immunity

Volumn 68, Issue 10, 2000, Pages 5749-5755

  Shen, X ^a   Lagergard, T ^a   Yang, Y ^a   Lindblad, M ^a   Fredriksson, M ^a   Holmgren, J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; STREPTOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; DOSE RESPONSE; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VACCINATION;

ANIMAL; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL VACCINES; CHOLERA TOXIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MUCOUS MEMBRANE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; SUPPORT, NON-U.S. GOV'T; VACCINATION; VACCINES, CONJUGATE;

EID: 0033801398     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.10.5749-5755.2000     Document Type: Article

References (30)

1. Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response
2. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina
3. Antibody responses in serum and lungs to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxiod
4. Group B betahemolytic streptococci causing pharyngitis
5. Oral administration of a streptococcal antigen coupling to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues
6. Colorimetric method for determination of sugars and related substances
7. A populatiun-based assessment of invasive disease due to group B streptococcus in non-pregnant adults
8. Prevention of group B streptococcal infection in neonates
9. Pharyngeal colonization of GBS: Detection by three methods
10. Comparison of an adherence domain and a structural region of Streptococcus mutans antigen I/II in protective immunity against dental caries in rats after intranasal immunization
11. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces
12. Serotype distribution of invasive group B streptococcal isolates in Maryland: Implications for vaccine formulation
13. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization
14. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R
15. Antibodies and antibody-secreting cell in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates
16. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretion of women
17. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid
18. Perinatal colonization of group B streptococcus - An epidemiological study in a Chinese population
19. Salivary, nasal, genital and systemic antibody responses in monkey immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit
20. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of human
21. Recombinant cholera toxin B subunit and gene fusion protein for oral vaccination
22. Group B streptococcus
23. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
24. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization
25. An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharities
26. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B streptococcus
27. Isolation and characterization of group B streptococci from genitourinary tracts in Japan
28. Group B streptococcal disease in the United States, 1990: Report from a multistate active surveillance system
29. Perinatal colonization of group B streptococcus: A study of 600 cases in Beijing Tiantan hospital
30. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes